Pharmacological approaches to the prevention of myocardial ischemia-reperfusion injury in experimental study and clinical practice
Early reperfusion of the infarct related coronary artery is essential for the preservation of myocardial tissue and improve clinical outcome. The establishment of pharmacological and mechanical reperfusion treatment was a major improvement in the management of patients with myocardial infarction. Ho...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2019-07-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/173356/173885 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849395830851633152 |
|---|---|
| author | S. M. Kozhukhov O. M. Parkhomenko |
| author_facet | S. M. Kozhukhov O. M. Parkhomenko |
| author_sort | S. M. Kozhukhov |
| collection | DOAJ |
| description | Early reperfusion of the infarct related coronary artery is essential for the preservation of myocardial tissue and improve clinical outcome. The establishment of pharmacological and mechanical reperfusion treatment was a major improvement in the management of patients with myocardial infarction. However, this therapy is often complicated by reperfusion injury including ventricular arrhythmias, myocardial stunning and micro-vascular dysfunction, in addition to significant cardiomyocyte death. The most important factors which contribute to the reperfusion injury are an overproduction of reactive oxygen species, intracellular calcium overload and inflammatory cell infiltration. Some of these mechanisms may be interrelated. From considerations of their nature, an attractive hypothesis has been that some or several of these harmful effects may be counteracted by pharmacological interventions. This hypothesis has mainly been studied in the experimental setting.
Objective – in this review, various pharmacological interventions to treat myocardial reperfusion injury including the antioxidant flavonols, glucose – insulin – potassium therapy, adenosine, melatonin, phosphocreatine and cyclosporin A etc.
Conclusions. The processes involved in reperfusion injury might provide targets for improved outcomes after myocardial infarction but that aim has thus far not been met in the clinic. By studying new molecules in different experimental settings and protocols, insight has been gained about important factors for possible future clinical applications of drugs with cardioprotective properties. |
| format | Article |
| id | doaj-art-b6b94493b3cc46e29b38250aeb25ab2e |
| institution | Kabale University |
| issn | 2306-4145 2310-1210 |
| language | English |
| publishDate | 2019-07-01 |
| publisher | Zaporizhzhia State Medical and Pharmaceutical University |
| record_format | Article |
| series | Zaporožskij Medicinskij Žurnal |
| spelling | doaj-art-b6b94493b3cc46e29b38250aeb25ab2e2025-08-20T03:39:29ZengZaporizhzhia State Medical and Pharmaceutical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102019-07-0121452853710.14739/2310-1210.2019.4.173356Pharmacological approaches to the prevention of myocardial ischemia-reperfusion injury in experimental study and clinical practiceS. M. KozhukhovO. M. ParkhomenkoEarly reperfusion of the infarct related coronary artery is essential for the preservation of myocardial tissue and improve clinical outcome. The establishment of pharmacological and mechanical reperfusion treatment was a major improvement in the management of patients with myocardial infarction. However, this therapy is often complicated by reperfusion injury including ventricular arrhythmias, myocardial stunning and micro-vascular dysfunction, in addition to significant cardiomyocyte death. The most important factors which contribute to the reperfusion injury are an overproduction of reactive oxygen species, intracellular calcium overload and inflammatory cell infiltration. Some of these mechanisms may be interrelated. From considerations of their nature, an attractive hypothesis has been that some or several of these harmful effects may be counteracted by pharmacological interventions. This hypothesis has mainly been studied in the experimental setting. Objective – in this review, various pharmacological interventions to treat myocardial reperfusion injury including the antioxidant flavonols, glucose – insulin – potassium therapy, adenosine, melatonin, phosphocreatine and cyclosporin A etc. Conclusions. The processes involved in reperfusion injury might provide targets for improved outcomes after myocardial infarction but that aim has thus far not been met in the clinic. By studying new molecules in different experimental settings and protocols, insight has been gained about important factors for possible future clinical applications of drugs with cardioprotective properties.http://zmj.zsmu.edu.ua/article/view/173356/173885myocardial infarctionreperfusiondrug therapy |
| spellingShingle | S. M. Kozhukhov O. M. Parkhomenko Pharmacological approaches to the prevention of myocardial ischemia-reperfusion injury in experimental study and clinical practice Zaporožskij Medicinskij Žurnal myocardial infarction reperfusion drug therapy |
| title | Pharmacological approaches to the prevention of myocardial ischemia-reperfusion injury in experimental study and clinical practice |
| title_full | Pharmacological approaches to the prevention of myocardial ischemia-reperfusion injury in experimental study and clinical practice |
| title_fullStr | Pharmacological approaches to the prevention of myocardial ischemia-reperfusion injury in experimental study and clinical practice |
| title_full_unstemmed | Pharmacological approaches to the prevention of myocardial ischemia-reperfusion injury in experimental study and clinical practice |
| title_short | Pharmacological approaches to the prevention of myocardial ischemia-reperfusion injury in experimental study and clinical practice |
| title_sort | pharmacological approaches to the prevention of myocardial ischemia reperfusion injury in experimental study and clinical practice |
| topic | myocardial infarction reperfusion drug therapy |
| url | http://zmj.zsmu.edu.ua/article/view/173356/173885 |
| work_keys_str_mv | AT smkozhukhov pharmacologicalapproachestothepreventionofmyocardialischemiareperfusioninjuryinexperimentalstudyandclinicalpractice AT omparkhomenko pharmacologicalapproachestothepreventionofmyocardialischemiareperfusioninjuryinexperimentalstudyandclinicalpractice |